vs

Side-by-side financial comparison of Groupon, Inc. (GRPN) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Groupon, Inc. is the larger business by last-quarter revenue ($132.7M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 1.8%). Groupon, Inc. produced more free cash flow last quarter ($53.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 3.8%).

Groupon, Inc. is an American e-commerce marketplace that connects subscribers with local merchants by offering activities, travel, goods, and services in 13 countries.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

GRPN vs PBYI — Head-to-Head

Bigger by revenue
GRPN
GRPN
1.8× larger
GRPN
$132.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+25.9% gap
PBYI
27.7%
1.8%
GRPN
More free cash flow
GRPN
GRPN
$38.6M more FCF
GRPN
$53.0M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
3.8%
GRPN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRPN
GRPN
PBYI
PBYI
Revenue
$132.7M
$75.5M
Net Profit
$7.9M
Gross Margin
90.4%
69.3%
Operating Margin
4.9%
22.7%
Net Margin
6.0%
Revenue YoY
1.8%
27.7%
Net Profit YoY
115.8%
EPS (diluted)
$0.21
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRPN
GRPN
PBYI
PBYI
Q4 25
$132.7M
$75.5M
Q3 25
$122.8M
$54.5M
Q2 25
$125.7M
$52.4M
Q1 25
$117.2M
$46.0M
Q4 24
$130.4M
$59.1M
Q3 24
$114.5M
$80.5M
Q2 24
$124.6M
$47.1M
Q1 24
$123.1M
$43.8M
Net Profit
GRPN
GRPN
PBYI
PBYI
Q4 25
$7.9M
Q3 25
$-118.4M
$8.8M
Q2 25
$20.3M
$5.9M
Q1 25
$7.2M
$3.0M
Q4 24
$-50.1M
Q3 24
$13.9M
$20.3M
Q2 24
$-10.0M
$-4.5M
Q1 24
$-12.3M
$-4.8M
Gross Margin
GRPN
GRPN
PBYI
PBYI
Q4 25
90.4%
69.3%
Q3 25
91.1%
77.7%
Q2 25
91.0%
76.5%
Q1 25
90.7%
77.1%
Q4 24
90.6%
76.4%
Q3 24
89.9%
63.9%
Q2 24
90.4%
77.4%
Q1 24
89.8%
75.5%
Operating Margin
GRPN
GRPN
PBYI
PBYI
Q4 25
4.9%
22.7%
Q3 25
1.8%
17.6%
Q2 25
10.4%
12.7%
Q1 25
1.6%
8.7%
Q4 24
2.0%
22.6%
Q3 24
-4.9%
27.4%
Q2 24
3.5%
-4.6%
Q1 24
6.0%
-5.3%
Net Margin
GRPN
GRPN
PBYI
PBYI
Q4 25
6.0%
Q3 25
-96.4%
16.2%
Q2 25
16.2%
11.2%
Q1 25
6.1%
6.5%
Q4 24
-38.4%
Q3 24
12.2%
25.2%
Q2 24
-8.1%
-9.6%
Q1 24
-10.0%
-11.0%
EPS (diluted)
GRPN
GRPN
PBYI
PBYI
Q4 25
$0.21
$0.26
Q3 25
$-2.92
$0.17
Q2 25
$0.46
$0.12
Q1 25
$0.17
$0.06
Q4 24
$-1.26
$0.40
Q3 24
$0.33
$0.41
Q2 24
$-0.25
$-0.09
Q1 24
$-0.33
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRPN
GRPN
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$296.1M
$97.5M
Total DebtLower is stronger
$342.8M
$22.7M
Stockholders' EquityBook value
$-42.6M
$130.3M
Total Assets
$670.4M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRPN
GRPN
PBYI
PBYI
Q4 25
$296.1M
$97.5M
Q3 25
$238.5M
$94.4M
Q2 25
$262.6M
$96.0M
Q1 25
$226.8M
$93.2M
Q4 24
$228.8M
$101.0M
Q3 24
$159.7M
$96.7M
Q2 24
$178.1M
$96.8M
Q1 24
$158.7M
$107.2M
Total Debt
GRPN
GRPN
PBYI
PBYI
Q4 25
$342.8M
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$246.0M
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
GRPN
GRPN
PBYI
PBYI
Q4 25
$-42.6M
$130.3M
Q3 25
$-59.6M
$115.3M
Q2 25
$51.2M
$104.7M
Q1 25
$45.5M
$97.1M
Q4 24
$40.8M
$92.1M
Q3 24
$40.0M
$71.1M
Q2 24
$40.2M
$48.5M
Q1 24
$41.2M
$51.0M
Total Assets
GRPN
GRPN
PBYI
PBYI
Q4 25
$670.4M
$216.3M
Q3 25
$608.2M
$202.9M
Q2 25
$647.4M
$194.9M
Q1 25
$608.2M
$196.2M
Q4 24
$612.7M
$213.3M
Q3 24
$548.0M
$220.7M
Q2 24
$572.8M
$205.0M
Q1 24
$580.5M
$214.1M
Debt / Equity
GRPN
GRPN
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
6.03×
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRPN
GRPN
PBYI
PBYI
Operating Cash FlowLast quarter
$56.6M
$14.4M
Free Cash FlowOCF − Capex
$53.0M
$14.4M
FCF MarginFCF / Revenue
40.0%
19.1%
Capex IntensityCapex / Revenue
2.7%
0.0%
Cash ConversionOCF / Net Profit
7.13×
TTM Free Cash FlowTrailing 4 quarters
$49.9M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRPN
GRPN
PBYI
PBYI
Q4 25
$56.6M
$14.4M
Q3 25
$-20.5M
$9.7M
Q2 25
$28.4M
$14.1M
Q1 25
$-22.0K
$3.6M
Q4 24
$67.0M
$15.6M
Q3 24
$-16.3M
$11.0M
Q2 24
$15.3M
$1.0M
Q1 24
$-10.1M
$11.2M
Free Cash Flow
GRPN
GRPN
PBYI
PBYI
Q4 25
$53.0M
$14.4M
Q3 25
$-24.6M
$9.7M
Q2 25
$25.2M
$14.1M
Q1 25
$-3.8M
$3.6M
Q4 24
$63.2M
$15.6M
Q3 24
$-19.7M
$11.0M
Q2 24
$10.8M
$1.0M
Q1 24
$-13.8M
FCF Margin
GRPN
GRPN
PBYI
PBYI
Q4 25
40.0%
19.1%
Q3 25
-20.0%
17.7%
Q2 25
20.0%
26.8%
Q1 25
-3.2%
7.7%
Q4 24
48.5%
26.4%
Q3 24
-17.2%
13.7%
Q2 24
8.7%
2.1%
Q1 24
-11.2%
Capex Intensity
GRPN
GRPN
PBYI
PBYI
Q4 25
2.7%
0.0%
Q3 25
3.3%
0.0%
Q2 25
2.6%
0.0%
Q1 25
3.2%
0.1%
Q4 24
2.9%
0.0%
Q3 24
3.0%
0.0%
Q2 24
3.6%
0.0%
Q1 24
3.0%
0.0%
Cash Conversion
GRPN
GRPN
PBYI
PBYI
Q4 25
7.13×
Q3 25
1.10×
Q2 25
1.40×
2.41×
Q1 25
-0.00×
1.21×
Q4 24
Q3 24
-1.17×
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRPN
GRPN

Service Local$94.8M71%
Other$35.6M27%
Service Travel$2.3M2%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons